Page last updated: 2024-10-17

salicylic acid and Uremia

salicylic acid has been researched along with Uremia in 13 studies

Scalp: The outer covering of the calvaria. It is composed of several layers: SKIN; subcutaneous connective tissue; the occipitofrontal muscle which includes the tendinous galea aponeurotica; loose connective tissue; and the pericranium (the PERIOSTEUM of the SKULL).

Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.

Research Excerpts

ExcerptRelevanceReference
"Limited studies indicate increased free fraction of valproic acid in uremia."3.69Reduced in vitro displacement of valproic acid from protein binding by salicylate in uremic sera compared with normal sera. Role of uremic compounds. ( Dasgupta, A; Jacques, M, 1994)

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-199010 (76.92)18.7374
1990's2 (15.38)18.2507
2000's1 (7.69)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SELIGSON, H1
KRAMER, B1
SELIGSON, D1
BALTRUSH, H1
Roman, S1
Gulyassy, PF4
Depner, TA2
Clegg, LS1
Lindup, WE1
Dasgupta, A3
Thompson, WC1
Jacques, M1
Biddle, DA1
Wells, A1
Jarrard, E2
Stanfel, LA1
Stanfel, L1
Mabuchi, H1
Nakahashi, H1
Bergström, J2
Jörnvall, H2
Zimmerman, L2
Gaspari, F1
Locatelli, M1
Tavares-Almeida, I1
Jarrard, EA1

Other Studies

13 other studies available for salicylic acid and Uremia

ArticleYear
PROCEDURE FOR ISOLATION AND IDENTIFICATION OF MINUTE AMOUNTS OF PHENOLIC ACIDS USING PAPER CHROMATOGRAPHY AND INFRARED SPECTROSCOPY.
    Analytical biochemistry, 1963, Volume: 6

    Topics: Benzoates; Chromatography; Chromatography, Paper; Fluorescence; Hippurates; Hydroxybenzoates; Resear

1963
Inhibition of salicylate binding to normal plasma by extracts of uremic fluids.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1984, Volume: 4, Issue:2

    Topics: Adult; Aged; Binding, Competitive; Body Fluids; Humans; Ligands; Middle Aged; Salicylates; Salicylic

1984
Drug binding defect of uraemic plasma: unlikely involvement of carbamoylated albumin.
    Biochemical pharmacology, 1982, Sep-01, Volume: 31, Issue:17

    Topics: Animals; Azo Compounds; Carbamates; Cattle; Humans; Pharmaceutical Preparations; Protein Binding; Sa

1982
Carbamazepine-salicylate interaction in normal and uremic sera: reduced interaction in uremic sera.
    Therapeutic drug monitoring, 1995, Volume: 17, Issue:2

    Topics: Carbamazepine; Drug Interactions; Hippurates; Humans; Salicylates; Salicylic Acid; Sulfates; Uremia

1995
Reduced in vitro displacement of valproic acid from protein binding by salicylate in uremic sera compared with normal sera. Role of uremic compounds.
    American journal of clinical pathology, 1994, Volume: 101, Issue:3

    Topics: Charcoal; Drug Interactions; Humans; In Vitro Techniques; Protein Binding; Salicylates; Salicylic Ac

1994
Unexpected suppression of free phenytoin concentration by salicylate in uremic sera due to the presence of inhibitors: MALDI mass spectrometric determination of molecular weight range of inhibitors.
    Life sciences, 2000, Volume: 66, Issue:2

    Topics: Anticonvulsants; Binding, Competitive; Charcoal; Creatinine; Drug Interactions; Gas Chromatography-M

2000
Contributions of hippurate, indoxyl sulfate, and o-hydroxyhippurate to impaired ligand binding by plasma in azotemic humans.
    Biochemical pharmacology, 1987, Dec-15, Volume: 36, Issue:24

    Topics: Blood Proteins; Calcium; Chlorides; Creatinine; Hippurates; Humans; Indican; Kidney Failure, Chronic

1987
Roles of hippurate and indoxyl sulfate in the impaired ligand binding by azotemic plasma.
    Advances in experimental medicine and biology, 1987, Volume: 223

    Topics: Blood Proteins; Hippurates; Humans; Indican; Protein Binding; Salicylates; Salicylic Acid; Toxins, B

1987
Displacement by anionic drugs of endogenous ligands bound to albumin in uremic serum.
    Therapeutic drug monitoring, 1988, Volume: 10, Issue:3

    Topics: Binding Sites; Furans; Hippurates; Humans; Indican; Indoleacetic Acids; Propionates; Protein Binding

1988
Middle molecules and the 7 C factor.
    Advances in experimental medicine and biology, 1987, Volume: 223

    Topics: Chromatography, Gel; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Glucuronate

1987
Determination of aspirin and salicylic acid in uremic patients' plasma using reversed-phase high-performance liquid chromatography.
    Therapeutic drug monitoring, 1987, Volume: 9, Issue:2

    Topics: Aspirin; Chromatography, High Pressure Liquid; Humans; Salicylates; Salicylic Acid; Uremia

1987
A method for separation of middle molecules by high performance liquid chromatography: application in studies of glucuronyl-o-hydroxyhippurate in normal and uremic subjects.
    Clinical nephrology, 1986, Volume: 25, Issue:2

    Topics: Chromatography, Gel; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Glucuronate

1986
Aromatic amino acid metabolites as potential protein binding inhibitors in human uremic plasma.
    Biochemical pharmacology, 1985, Jul-15, Volume: 34, Issue:14

    Topics: Amino Acids; Blood Proteins; Hippurates; Humans; Indoles; Kynurenic Acid; Protein Binding; Quinoline

1985